NEWARK, CA / ACCESS Newswire / February 21, 2025 / Protagonist Therapeutics (NASDAQ:PTGX) ("Protagonist" or "the Company") today reported financial results for the fourth quarter and full year ended ...

(formerly JNJ-2113) milestone earned in Q4 2024, received in January 2025PN-881, a potential best-in-class oral IL-17 receptor antagonist peptide nominated as a development candidate ...

Prime Minister Narendra Modi on Thursday interacted with the key leaders of the National Democratic Alliance (NDA) on the ...

PM Narendra Modi said all upcoming elections will be fought by the NDA as a single bloc, signalling that the coalition led by ...